TDG

TransDigm Group
D

TDG

Arincen67/100B

TransDigm Group P/E ratio

TransDigm Group's P/E ratio is 34.92: its share price of 1,241.04 over its earnings per share of 35.54 over the last twelve months.

Today
34.92
Forward P/E, next 12 months
25.11
PEG ratio
1.74
Median, 5 years
47.35
Low, 5 years
32.65
High, 5 years
79.25

P/E ratio = price ÷ EPS (last 12 months) = 1,241.04 ÷ 35.54 = 34.92

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is TransDigm Group's P/E high compared with its own history?

TransDigm Group's P/E of 34.9 is near the bottom of its 5-year range (32.6 to 79.3, median 47.3). Analysts expect slower growth than in recent years, so the low P/E may be deserved.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal yearPeriod endingP/E ratioForward P/EMarket capNet income
FY2028 · Estimate30 Sept 202822.32———
FY2027 · Estimate30 Sept 202725.52———
Today34.9225.1168.60B2.13B
FY202530 Sept 202536.9932.0276.71B2.07B
FY202430 Sept 202448.1039.0182.49B1.72B
FY202330 Sept 202337.1328.4248.23B1.30B
FY202230 Sept 202235.2320.7530.54B867.00M
FY202130 Sept 202153.5637.0536.47B681.00M
FY202030 Sept 202038.8940.9527.22B700.00M
FY201930 Sept 201932.8736.2829.30B891.31M
FY201830 Sept 201821.5020.6820.58B957.06M
FY201730 Sept 201723.7814.4914.20B596.89M
FY201630 Sept 201627.6923.5516.24B586.41M
FY201530 Sept 201526.8918.6312.02B447.21M
FY201430 Sept 201434.2321.1010.51B306.91M
FY201330 Sept 201325.2318.157.64B302.79M
FY201230 Sept 201223.4921.387.63B324.97M
FY201130 Sept 2011—13.574.36B-19.91M
FY201030 Sept 201020.0914.953.28B163.45M
FY200930 Sept 200916.0619.162.62B162.90M
FY200830 Sept 200812.3011.641.64B133.13M
FY200730 Sept 200723.7719.472.11B88.65M
FY200630 Sept 200643.1812.991.08B25.12M
FY200530 Sept 200530.71—1.07B34.69M
FY200430 Sept 200478.19—1.07B13.62M
FY200330 Sept 2003——177.57M-75.73M
FY200230 Sept 20020.09—2.89M30.63M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

See also:Market cap,P/S ratio,Current ratio,All ratios

Common questions about TransDigm Group's P/E ratio

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.